FDA Inspection 1222136 — Maxim Biomedical Inc.
The FDA completed an inspection of Maxim Biomedical Inc. on Nov 2, 2023 in Rockville, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 2, 2023
- Fiscal Year
- 2024
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Rockville, MD (United States)